Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Is sympathetic hyperactivity a coronary risk factor?]

R Fogari1, A Zoppi

  • 1Dipartimento di Medicina Interna e Terapia Medica, Università degli Studi, Pavia.

Cardiologia (Rome, Italy)
|December 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age affects the perception of limb length discrepancy in patients with and without a total hip arthroplasty.

Hip international : the journal of clinical and experimental research on hip pathology and therapy·2017
Same author

Wavelength dispersion of the local field intensity in silver-gold nanocages.

Physical chemistry chemical physics : PCCP·2015
Same author

Functionalized Au/Ag nanocages as a novel fluorescence and SERS dual probe for sensing.

Journal of colloid and interface science·2013
Same author

Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus.

Diabetes, obesity & metabolism·2011
Same author

Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial.

Diabetic medicine : a journal of the British Diabetic Association·2011
Same author

Different effects of aliskiren and losartan on fibrinolysis and insulin sensitivity in hypertensive patients with metabolic syndrome.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2010
Same journal

[Prevention in coronary postangioplasty restenosis with omega-3 fatty acids. Results of the Italian study on prevention of restenosis with esapent (ESPRIT)].

Cardiologia (Rome, Italy)·2002
Same journal

[Results of GISSI Prevenzione: diet, drugs, and cardiovascular risk. Researchers of GISSI Prevenzione].

Cardiologia (Rome, Italy)·2002
Same journal

[New therapeutic strategies in heart failure. Which patients need defibrillation backup?].

Cardiologia (Rome, Italy)·2002
Same journal

[Electromechanical re-synchronization with sequential heart stimulation as a new non-pharmacologic treatment of advanced heart failure. Physiopathologic features and clinical results].

Cardiologia (Rome, Italy)·2002
Same journal

[New therapeutic strategies in heart failure. Pharmacologic therapy].

Cardiologia (Rome, Italy)·2002
Same journal

[Genetics as a guide for antihypertensive therapy: future perspectives].

Cardiologia (Rome, Italy)·2002
See all related articles

Enhanced sympathetic nervous activity is linked to coronary heart disease and hypertension. Beta-blocker trials suggest its role in reducing mortality after myocardial infarction.

Area of Science:

  • Cardiovascular Physiology
  • Autonomic Nervous System Research
  • Clinical Cardiology

Context:

  • Sympathetic nervous system activity influences cardiovascular health.
  • Circadian patterns of catecholamines correlate with coronary events.
  • Elevated sympathetic tone is observed in myocardial infarction and hypertension.

Purpose:

  • To explore the role of enhanced sympathetic nervous activity in cardiovascular disease.
  • To examine the relationship between sympathetic activation and coronary heart disease progression.
  • To assess the impact of sympathetic hyperactivity on hypertension and its sequelae.

Summary:

  • Clinical and experimental data indicate sympathetic nervous system hyperactivity contributes to coronary heart disease pathogenesis and progression.

Related Experiment Videos

  • This hyperactivity is associated with circadian patterns of plasma catecholamines, early morning coronary events, and myocardial infarction.
  • Evidence suggests a role in essential hypertension, left ventricular hypertrophy, and vascular hypertrophy.

    • Impact:

    • Understanding sympathetic nervous system's role may reveal new therapeutic targets for cardiovascular diseases.
    • Beta-blocker efficacy in myocardial infarction indirectly supports the significance of sympathetic activation.
    • Further research is needed to clarify if sympathetic hyperactivity is an independent cardiovascular risk factor.